AI is rapidly changing how we work, live, and make decisions. But what happens when that transformation reaches healthcare and ultimately, the patient?

In this episode of The Early Signs Podcast, our Co-Founder and CEO Prashant Warier sits down with Dr. Sunil Verma, SVP & Global Head of Oncology at AstraZeneca, for a wide-ranging conversation on what AI could mean for the future of healthcare and humanity.

From giving patients a stronger voice in their own care to transforming clinical decision-making, drug discovery, and healthcare delivery, Dr. Verma explores both the possibilities and the challenges that lie ahead.

He believes the next three years could define the incredible opportunity AI has to unleash.

Together, they explore:

* How AI could give patients a stronger voice in their own care

* Why treatment decisions may become increasingly complex as options multiply

* The promise and limitations of AI in drug discovery and clinical trials

* What it could take to move from "sick care" to more proactive, continuous care

* How organisations can build AI literacy and adoption

* The ethical guardrails needed as AI becomes more powerful

If you work in healthcare, life sciences, technology, or are simply curious about where AI is headed—this conversation offers a look at what comes next.

Guest:

Dr. Sunil Verma

SVP & Global Head, Oncology Franchise, AstraZeneca

Host:

Prashant Warier

Co-Founder & CEO, Qure.ai

Everyone is talking about AI in healthcare but very few are talking about what it actually takes to build it.

In Episode 2 of Early Signs Podcast, Qure.ai Co-founder & CEO Prashant Warier sits down with Dr. Amit Gupta, Executive Vice Chair of Radiology at University Hospitals Cleveland Medical Center and Professor at Case Western Reserve University.

But this isn't just another conversation about AI, It's a conversation about clinicians becoming builders.

Dr. Amit Gupta shares how he's using AI to build tools for radiologists, why workflows matter more than algorithms, what healthcare gets wrong about AI adoption, and how partnerships between clinicians and technology companies can help bring earlier diagnosis into everyday clinical practice.

Whether you're a clinician, researcher, startup founder, engineer or simply curious about the future of medicine, this episode offers a practical look at where healthcare AI is really headed.

Guest:

Dr. Amit Gupta

Thoracic Radiologist; Imaging Informatics Expert; Division Chief of Cardiothoracic Imaging & Executive Vice Chair of Radiology, University Hospitals Cleveland Medical Center

Host:

Prashant Warier

Co-Founder & CEO, Qure.ai

What could the future of healthcare look like when governments, healthcare providers, and technology leaders work together to expand access to cost-effective healthcare solutions?

In the first episode of Early Signs, Prashant Warier, Co-Founder & CEO of Qure.ai, speaks with Dr. Neil Buddy Shah, CEO of the Clinton Health Access Initiative (CHAI) and Chair of Anthropic's Long-Term Benefit Trust, on global health equity, AI in healthcare policy, data-driven global health infrastructure, and more.

The conversation explores how countries can use AI to strengthen universal health coverage, support frontline health workers, improve access to diagnostics, and make better use of existing resources. The discussion also examines the role of government leadership, regulatory safeguards, patient safety, and public trust in shaping the future of healthcare.

From point-of-care diagnostics and community-based care models to national health intelligence systems, this episode looks at how technology can help countries accelerate progress toward better health outcomes while working within real-world workforce and infrastructure constraints.

Listen to the full episode of our podcast today.

Guest:

Dr. Neil Buddy Shah

CEO, Clinton Health Access Initiative (CHAI);

Chair, Anthropic's Long-Term Benefit Trust

Host:

Prashant Warier

Co-Founder & CEO, Qure.ai